These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-001991-37 A pilot study investigating the effects of a combination of local and systemic anti-inflammatory adjuncts in patients undergoing vitrectomy and silicone oil for established Proliferative Vitreoretinop... 2007-11-01 due-trials
Not reported 2005-002389-13 Endothelial Lamellar Keratoplasty (ELK) with Tisseel adhesive. 2007-02-09 due-trials
Completed, but no date, and reported results 2005-002391-14 Pulsed Intravenous Methylprednisolone for Ocular Pemphigoid- A Pilot Study bad-data
Reported results 2006-000653-22 The UK Glaucoma Treatment Study 2011-07-19 due-trials
Reported results 2006-001544-31 A randomised, double-masked, phase 3 study of the efficacy and safety of Avastin® (bevacizumab) intravitreal injections compared to best available therapy in subjects with choroidal neovascularizatio... 2008-12-02 due-trials
Reported results 2006-004826-10 An observational case series to assess the effects of intravitreal Bevacizumab on eyes with neovascular glaucoma 2009-04-15 due-trials
Reported results Terminated 2006-005008-15 Exploratory study of intravitreal clindamycin and dexamethasone in the treatment of acute toxoplasma chorioretinitis associated vitritis 2009-12-09 due-trials
Reported results Terminated 2006-006728-20 The use of intraocular methotrexate to treat uveitis: a safety and efficacy study 2009-09-16 due-trials
Reported results 2007-000705-30 efficacy of pegaptanib sodium (macugen) on uveitic cystoid macular oedema: an exploratory study 2010-06-28 due-trials
Reported results Terminated 2007-000780-21 A randomised, single-masked, Phase IV pilot study of the efficacy and safety of adjunctive intravitreal Avastin® (bevacizumab) in the prevention of early postoperative vitreous haemorrhage following d... 2008-08-22 due-trials
Reported results 2007-000847-89 Full Title of Study: Diabetic macular oedema: a prospective randomised trial of management with intravitreal bevacizumab (Avastin) versus conventional laser therapy 2010-07-26 due-trials
Reported results 2007-005138-35 Triamcinolone acetonide to prevent PVR in eyes undergoing vitreoretinal surgery for open globe trauma 2013-12-02 due-trials
Reported results 2008-003689-24 Lotemax in the treatment of chronic anterior uveitis: a pilot study 2010-06-28 due-trials
Reported results 2008-007984-17 Pilot randomised placebo-controlled double-masked clinical trial of subconjunctival Bevacizumab on eyes with recent onset of corneal neovascularisation 2014-01-20 due-trials
Reported results 2010-021722-35 Diabetic macula oedema: A prospective randomised study comparing the detailed functional and anatomical changes of repeated pan anti-VEGF therapy with ranibizumab versus conventional macular laser the... 2012-07-16 due-trials
Reported results 2010-024062-22 A prospective, randomised controlled trial of Ranibizumab pre-treatment in Diabetic Vitrectomy – a pilot study. 2013-11-01 due-trials
Reported results 2011-001869-41 An exploratory study of ranibizumab (Lucentis) for treatment of uveitic patients with refractory cystoid macular oedema. 'The LIMO study' 2014-06-18 due-trials
Reported results Terminated 2011-003304-20 Randomised Controlled Trial of Intravitreal therapy with Avastin compared to Observation in Patients with Diabetic Ischaemic Macular Oedema ‘The DIME study’ 2012-10-15 due-trials
Reported results 2011-003339-74 A Prospective Randomised Controlled Trial of Intravitreal Ozurdex and Macular Laser Therapy versus Macular Laser Therapy only in Diabetic Macular Oedema (OZLASE study) 2013-10-22 due-trials
Reported results 2011-004498-96 Ozurdex in proliferative vitreoretinopathy; a randomised control trial 2015-02-17 due-trials
Reported results 2012-003661-17 A Multicentre Prospective Open-label Randomised Clinical Trial Comparing the Efficacy of Fixed versus PRN dosing of 700 µg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) in patients... 2014-11-10 due-trials
Reported results Terminated 2013-000031-27 Intravitreal Ranibizumab (Lucentis) Therapy in Patients with Diabetic Ischaemic Macular Oedema (DIME) 2014-02-04 due-trials
Reported results Terminated 2013-000395-15 The use of bevacizumab as a modulator of wound healing following trabeculectomy surgery: A Single Centre Randomised Controlled Phase III Pilot Study. 2019-09-05 due-trials
Reported results 2013-003272-12 Clinical Efficacy and Mechanistic Evaluation of Aflibercept for Proliferative Diabetic Retinopathy 2016-12-21 due-trials
Reported results 2014-000272-26 A Multicentre Phase III Double-masked Randomised Controlled Non-Inferiority Trial comparing the clinical and cost effectiveness of intravitreal therapy with ranibizumab (Lucentis) vs aflibercept (Eyle... 2018-11-21 due-trials
Other 2014-002193-37 A phase 3 multi-centre double-masked randomised controlled trial of adjunctive intraocular and periocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal s... not-yet-due
Reported results 2014-002381-73 Individualizing therapy for neovascular age-related macular degeneration with aflibercept 2018-01-26 due-trials
Reported results 2015-003723-65 Aflibercept (Eylea®) for macular oedema associated with underlying Retinitis Pigmentosa (AMOUR) 2017-07-31 due-trials
Reported results 2016-002523-28 A Pilot Study Evaluating the Effect of Intravitreal Fluocinolone Acetonide (0.19mg) in Patients with Retinitis Pigmentosa 2016-10-20 due-trials